J
$ Value
$0
Shares
62,815
Price
$0
Filed
Jan 30
Insider
Name
Robinson Chandler
Title
Chief Executive Officer
CIK
0001727334
Roles
Director
Officer
Transaction Details
Transaction Date
2025-01-28
Code
J
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
62,815
Footnotes
Pro rata liquidating distribution from Tactic Pharma, LLC ("Tactic"), of which the reporting person is a non-controlling member. In prior reports, the reporting person reported beneficial ownership of 272,026 shares of Monopar Therapeutics Inc. common stock held by Tactic. | Represents shares held by the Chandler D. Robinson Irrevocable Trust U/A dated May 20, 2020.
Filing Info
Robinson Chandler's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-31 | MNPR | M | — |
| 2026-03-31 | MNPR | F | $108K |
| 2026-03-31 | MNPR | M | $0 |
| 2025-12-31 | MNPR | M | — |
| 2025-12-31 | MNPR | F | $167K |
| 2025-12-31 | MNPR | M | $0 |
| 2025-12-02 | MNPR | A | $0 |
| 2025-12-02 | MNPR | A | $0 |
| 2025-09-30 | MNPR | M | — |
| 2025-09-30 | MNPR | F | $216K |
Other Insiders at MNPR (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Robinson Chandler
Chief Executive Officer
|
— | — | 2026-03-31 |
|
Rodriguez Susan
CCSO
|
— | — | 2026-03-02 |
|
Cittadine Andrew
Chief Operating Officer
|
— | — | 2026-03-31 |